Shares of Inspire Medical Systems INSP rose 9.53% in after-market trading after the company reported Q3 results.
Quarterly Results
Earnings per share were down 14.71% over the past year to ($0.39), which beat the estimate of ($0.72).
Revenue of $35,842,000 higher by 71.81% from the same period last year, which beat the estimate of $22,750,000.
Outlook
Earnings guidance hasn't been issued by the company for now.
The upcoming fiscal year's revenue expected to be between $110,000,000 and $112,000,000.
Details Of The Call
Date: Nov 02, 2020
Time: 05:00 PM
ET Webcast URL: http://public.viavid.com/player/index.php?id=141564
Price Action
Company's 52-week high was at $135.20
Company's 52-week low was at $40.53
Price action over last quarter: Up 11.81%
Company Profile
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.